Marc A. Kastner - Nov 15, 2022 Form 4 Insider Report for BRUKER CORP (BRKR)

Role: Director
Signature: /s/ Michael A Simone, Attorney-in-Fact
Stock symbol: BRKR
Transactions as of: Nov 15, 2022
Transactions value $: -$467,490
Form type: 4
Date filed: 11/17/2022, 03:03 PM
Previous filing: Jan 6, 2022
Next filing: Jan 9, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BRKR	Common Stock	Options Exercise	$240K	+10K	+124.21%	$24.00	18.1K	Nov 15, 2022	Direct
transaction	BRKR	Common Stock	Sale	-$707K	-10K	-55.4%	$70.75	8.05K	Nov 15, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BRKR	Stock Option (Right to Purchase)	Options Exercise	$0	-10K	-100%	$0.00^*	0	Nov 15, 2022	Common Stock	10K	$24.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.545 to $71.120, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The stock option granted to the Reporting Person on January 5, 2016 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.545 to $71.120, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The stock option granted to the Reporting Person on January 5, 2016 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.